SPONSOR
AHS Cancer Control Alberta
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: Glioblastoma MultiformeCancerMalnourishmentNutritional DeficiencyUndernutritionHepatitis ImmunePneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Glioblastoma Multiforme, Cancer, Malnourishment, Nutritional Deficiency.
The trial portfolio spans Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — AHS Cancer Control Alberta
How many clinical trials has AHS Cancer Control Alberta sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by AHS Cancer Control Alberta, of which 5 are actively recruiting participants. These trials cover conditions including Glioblastoma Multiforme, Cancer, Malnourishment. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does AHS Cancer Control Alberta research focus on?
AHS Cancer Control Alberta clinical trials span Glioblastoma Multiforme, Cancer, Malnourishment, Nutritional Deficiency, Undernutrition, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a AHS Cancer Control Alberta clinical trial?
To participate in a AHS Cancer Control Alberta trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all AHS Cancer Control Alberta trials with current recruitment status updated daily.
Clinical Trials by AHS Cancer Control Alberta
NCT04765514 Phase 2
Recruiting
Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients
Glioblastoma Multiforme
NCT05413473 Phase 1, Phase 2
Recruiting
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
Cancer
NCT05379712 Phase 2
Recruiting
Nutritional Supplementation in Head and Neck Cancers
Malnourishment
NCT05345847
Recruiting
Steroid Sparing in Immune Related Hepatitis (irH)
Hepatitis Immune
NCT06860542 Phase 2
Recruiting
Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
Pneumonitis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology